Bernard Cazelles1,2,3, Benjamin Nguyen-Van-Yen4, Clara Champagne5,6, Catherine Comiskey7. 1. UMMISCO, Sorbonne Université, Paris, France. cazelles@biologie.ens.fr. 2. INRAE, Université Paris-Saclay, MaIAGE, Jouy-en-Josas, France. cazelles@biologie.ens.fr. 3. Eco-Evolution Mathématique, IBENS, UMR 8197, CNRS, Ecole Normale Supérieure, Paris, France. cazelles@biologie.ens.fr. 4. Eco-Evolution Mathématique, IBENS, UMR 8197, CNRS, Ecole Normale Supérieure, Paris, France. 5. Swiss Tropical and Public Health Institute, Basel, Switzerland. 6. Universty of Basel, Basel, Switzerland. 7. School of Nursing and Midwifery, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Abstract
BACKGROUND: In Ireland and across the European Union the COVID-19 epidemic waves, driven mainly by the emergence of new variants of the SARS-CoV-2 have continued their course, despite various interventions from governments. Public health interventions continue in their attempts to control the spread as they wait for the planned significant effect of vaccination. METHODS: To tackle this challenge and the observed non-stationary aspect of the epidemic we used a modified SEIR stochastic model with time-varying parameters, following Brownian process. This enabled us to reconstruct the temporal evolution of the transmission rate of COVID-19 with the non-specific hypothesis that it follows a basic stochastic process constrained by the available data. This model is coupled with Bayesian inference (particle Markov Chain Monte Carlo method) for parameter estimation and utilized mainly well-documented Irish hospital data. RESULTS: In Ireland, mitigation measures provided a 78-86% reduction in transmission during the first wave between March and May 2020. For the second wave in October 2020, our reduction estimation was around 20% while it was 70% for the third wave in January 2021. This third wave was partly due to the UK variant appearing in Ireland. In June 2020 we estimated that sero-prevalence was 2.0% (95% CI: 1.2-3.5%) in complete accordance with a sero-prevalence survey. By the end of April 2021, the sero-prevalence was greater than 17% due in part to the vaccination campaign. Finally we demonstrate that the available observed confirmed cases are not reliable for analysis owing to the fact that their reporting rate has as expected greatly evolved. CONCLUSION: We provide the first estimations of the dynamics of the COVID-19 epidemic in Ireland and its key parameters. We also quantify the effects of mitigation measures on the virus transmission during and after mitigation for the three waves. Our results demonstrate that Ireland has significantly reduced transmission by employing mitigation measures, physical distancing and lockdown. This has to date avoided the saturation of healthcare infrastructures, flattened the epidemic curve and likely reduced mortality. However, as we await for a full roll out of a vaccination programme and as new variants potentially more transmissible and/or more infectious could continue to emerge and mitigation measures change silent transmission, challenges remain.
BACKGROUND: In Ireland and across the European Union the COVID-19 epidemic waves, driven mainly by the emergence of new variants of the SARS-CoV-2 have continued their course, despite various interventions from governments. Public health interventions continue in their attempts to control the spread as they wait for the planned significant effect of vaccination. METHODS: To tackle this challenge and the observed non-stationary aspect of the epidemic we used a modified SEIR stochastic model with time-varying parameters, following Brownian process. This enabled us to reconstruct the temporal evolution of the transmission rate of COVID-19 with the non-specific hypothesis that it follows a basic stochastic process constrained by the available data. This model is coupled with Bayesian inference (particle Markov Chain Monte Carlo method) for parameter estimation and utilized mainly well-documented Irish hospital data. RESULTS: In Ireland, mitigation measures provided a 78-86% reduction in transmission during the first wave between March and May 2020. For the second wave in October 2020, our reduction estimation was around 20% while it was 70% for the third wave in January 2021. This third wave was partly due to the UK variant appearing in Ireland. In June 2020 we estimated that sero-prevalence was 2.0% (95% CI: 1.2-3.5%) in complete accordance with a sero-prevalence survey. By the end of April 2021, the sero-prevalence was greater than 17% due in part to the vaccination campaign. Finally we demonstrate that the available observed confirmed cases are not reliable for analysis owing to the fact that their reporting rate has as expected greatly evolved. CONCLUSION: We provide the first estimations of the dynamics of the COVID-19 epidemic in Ireland and its key parameters. We also quantify the effects of mitigation measures on the virus transmission during and after mitigation for the three waves. Our results demonstrate that Ireland has significantly reduced transmission by employing mitigation measures, physical distancing and lockdown. This has to date avoided the saturation of healthcare infrastructures, flattened the epidemic curve and likely reduced mortality. However, as we await for a full roll out of a vaccination programme and as new variants potentially more transmissible and/or more infectious could continue to emerge and mitigation measures change silent transmission, challenges remain.
Authors: Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt Journal: Nature Date: 2020-06-08 Impact factor: 49.962
Authors: C Jessica E Metcalf; Jeremy Farrar; Felicity T Cutts; Nicole E Basta; Andrea L Graham; Justin Lessler; Neil M Ferguson; Donald S Burke; Bryan T Grenfell Journal: Lancet Date: 2016-04-05 Impact factor: 79.321
Authors: Laura Di Domenico; Giulia Pullano; Chiara E Sabbatini; Pierre-Yves Boëlle; Vittoria Colizza Journal: BMC Med Date: 2020-07-30 Impact factor: 8.775
Authors: Seamus O'Reilly; Verena Murphy; Eibhlin Mulroe; Lisa Tucker; Fiona Carragher; Jacinta Marron; Aoife M Shannon; Ken Rogan; Roisin M Connolly; Bryan T Hennessy; Ray S McDermott Journal: Cancers (Basel) Date: 2022-04-30 Impact factor: 6.575